Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Amglidia
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Amglidia 0.6mg/ml oral suspension with 1ml oral syringe
0601021H0BNAAAP
|
Amglidia | Glibenclamide | Endocrine System | No data available |
|
Amglidia 0.6mg/ml oral suspension with 5ml oral syringe
0601021H0BNABAP
|
Amglidia | Glibenclamide | Endocrine System | No data available |
|
Amglidia 6mg/ml oral suspension with 1ml oral syringe
0601021H0BNACAQ
|
Amglidia | Glibenclamide | Endocrine System | No data available |
|
Amglidia 6mg/ml oral suspension with 5ml oral syringe
0601021H0BNADAQ
|
Amglidia | Glibenclamide | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.